Biktarvy, formally known as bictegravir, represents a powerful single-tablet therapy for managing HIV infection. This drug combines three crucial antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It operates by preventing the virus's ability to copy within the body, significantly lowering the viral load. For many indivi